Linbing Qu
Impact in
-
- HIV Research and Treatment
Papers in
-
- Metabolism, Diabetes, and Cancer 3
-
- SARS-CoV-2 and COVID-19 Research 5
- COVID-19 Clinical Research Studies 4
- Co-authors
- Ling Chen (20 shared papers)Min Guan (3 shared papers)Wenjuan Tan (3 shared papers)Chi‐Wai Wong (2 shared papers)Jinsong Liu (3 shared papers)Liqiang Feng (10 shared papers)Meng Yang (1 shared paper)Haobo Pan (1 shared paper)
In The Last Decade
Linbing Qu
21 papers receiving 323 citations
Peers
Comparison fields: 5 of 65
- Virology 19
- Hepatology 28
- Infectious Diseases 56
- Epidemiology 92
- Biochemistry 19
Countries citing papers authored by Linbing Qu
This map shows the geographic impact of Linbing Qu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Linbing Qu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Linbing Qu more than expected).
Fields of papers citing papers by Linbing Qu
This network shows the impact of papers produced by Linbing Qu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Linbing Qu. The network helps show where Linbing Qu may publish in the future.
Co-authors
The 25 scholars most cited alongside Linbing Qu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 57 | |
| 2 | 2010 | 51 | |
| 3 | 2013 | 31 | |
| 4 | 2021 | 24 | |
| 5 | 2019 | 20 | |
| 6 | 2017 | 20 | |
| 7 | 2009 | 18 | |
| 8 | 2024 | 17 | |
| 9 | 2018 | 15 | |
| 10 | 2020 | 13 | |
| 11 | 2015 | 13 | |
| 12 | 2023 | 12 | |
| 13 | 2022 | 10 | |
| 14 | 2018 | 6 | |
| 15 | 2022 | 4 | |
| 16 | 2024 | 3 | |
| 17 | 2023 | 3 | |
| 18 | 2024 | 3 | |
| 19 | 2024 | 2 | |
| 20 | 2020 | 2 |
About Linbing Qu
Linbing Qu is a scholar working on Molecular Biology, Infectious Diseases, Epidemiology, Genetics and Immunology, having authored 22 papers that have together received 325 indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (5 papers), COVID-19 Clinical Research Studies (4 papers), Metabolism, Diabetes, and Cancer (3 papers), Lipid metabolism and biosynthesis (3 papers), Liver Disease Diagnosis and Treatment (3 papers), HIV Research and Treatment (2 papers), Virus-based gene therapy research (2 papers) and T-cell and B-cell Immunology (2 papers). The work is most often cited by research in Virology (19 citations), Hepatology (28 citations), Infectious Diseases (56 citations), Epidemiology (92 citations) and Biochemistry (19 citations). Linbing Qu has collaborated with scholars based in China, Hong Kong and Australia. Frequent co-authors include Ling Chen, Min Guan, Wenjuan Tan, Chi‐Wai Wong, Jinsong Liu, Liqiang Feng, Meng Yang, Haobo Pan, Qingli Liu and Tongling Huang. Their work appears in journals such as Emerging Microbes & Infections, Journal of Virology, Microbiology Spectrum, The FASEB Journal and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.